Abstract:Transient receptor potential canonical channels (TRPCs) are calcium-permeable, nonselective cation channels. Human TRPC channels contain six functional members: TRPC1, and TRPC3-7, and they are widely distributed in many tissues. These channels are involved in numerous physiological processes, including regulating myogenic tone and blood pressure, endothelial barrier function regulation, hypoxic pulmonary vasoconstriction, neuronal function, and kidney function. They are also associated with several diseases, including traumatic brain injury, pathologic cardiac hypertrophy, atherosclerosis, the development of cancer, and diabetes. Specifically, gain-of-function mutations of the TRPC6 gene in humans cause focal segmental glomerular sclerosis (FSGS), a chronic kidney disease for which there is no effective treatment. Consequently, TRPC channels serve as drug targets for several diseases, including FSGS and anxiety. Recent developments in single-particle cryo-EM permit the determination of the structures of multiple TRPC channel members (TRPC3, TRPC4, TRPC5, and TRPC6) in multiple states at near-atomic resolutions. These structures demonstrate that TRPC channels are tetramers composed of two layers: The upper transmembrane domain (TMD) and the lower intracellular domain (ICD). The ICD layer consists of ankyrin repeat domains (ARD), linker helices domains (LHD), the TRP helix, and C terminal helices. The four protomers' voltage sensor-like domains (VSLD) and pore domains form the TMD layer. ICD has a bell-like shape with a large central chamber and caps below TMD. The structures reveal both the inhibitory calcium binding site in ICD and the activating calcium binding site in TMD. Calcium binding to the inhibitory site results in the closure of the ICD and the restriction of ion flow through the ICD, whereas calcium dissociation from the inhibitory site results in the opening of the ICD and the unrestricted flow of ions through the ICD. Calcium binding to the activating site increases its activity. Additionally, the binding pockets and binding poses of several small molecule modulators of TRPC channels are identified. Their binding sites are distributed across three distinct regions of TMD. One of the pockets partially overlaps the endogenous activating lipid diacylglycerol-binding site, while another partially overlaps the activating calcium-binding site. In conclusion, these structural findings combined with functional analysis, particularly site-directed mutagenesis data, reveal how intracellular calcium concentrations bi-directionally modulate the TRPC channel, how small molecules bind and tune the activity of TRPC channels, and how the gain-of-function mutations found in FSGS patients over-activate the intracellular calcium signaling of kidney podocytes via the TRPC6 channel in a positive feedback manner. These developments lay the groundwork for a more in-depth mechanistic dissection of TRPC channels. They would also facilitate the discovery of drugs that target TRPC channels to treat associated diseases.

PIP2 regulation of TRPC5 channel activation and desensitization

PIP2 modulates TRPC3 activity via TRP helix and S4-S5 linker

PIP2 depletion promotes TRPV4 channel activity in mouse brain capillary endothelial cells

The spatial distribution of GPCR and Gβγ activity across a cell dictates PIP3 dynamics

Periphery Pre-S1 and S1 helix nexus for PIP2 at TRPC3 channel

Advances in the structural mechanism of TRPC channels

TRPM5 activation depends on a synergistic effect of calcium and PKC phosphorylation

Autoinhibition of TRPV6 Channel and Regulation by PIP2

Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gβγ

A PIP2 substitute mediates voltage sensor-pore coupling in KCNQ activation

Bidirectional Allosteric Coupling between PIP2 Binding and the Pore of the Oncochannel TRPV6

Transient receptor potential melastatin 3 is a phosphoinositide-dependent ion channel

Dual regulation of IP3 receptors by IP3 and PIP2 controls the transition from local to global Ca2+ signals

Structural Determinants of Pip2 Regulation of Inward Rectifier KATP Channels

Structural basis for the regulation of inositol trisphosphate receptors by Ca2+ and IP3

Diacylglycerol kinases regulate TRPV1 channel activity

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel

Structural basis for activation and gating of IP3 receptors

Phosphatidylinositol 4,5-bisphosphate (PIP2) and Ca2+ are both required to open the Cl− channel TMEM16A

Understanding the Molecular Mechanism of PLCε Regulation and G Protein‐Mediated Activation

The Role of Phosphoinositides in the Desensitization of TRPM8 Currents